Nuvation Bio (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 29, 2019
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $275,000,000
Company Info
- Founders
- David Hung, M.D.
- Company Description
- Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
- Market
- Oncology
- Location
- New York, NY, USA
- Coinvestors
- Aisling Capital, Altitude Life Science Ventures, Boxer Capital of the Tavistock Group, EcoR1 Capital, EDBI, Fidelity Management & Research Company, Omega Funds, Pavilion Capital, Perceptive Advisors, Redmile Group, Surveyor Capital, The Baupost Group